Report Detail
Global (United States, European Union and China) Irritable Bowel Syndrome (IBS) Therapeutics Market Research Report 2019-2025
- RnM3579326 |
- 22 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.
In 2019, the market size of Irritable Bowel Syndrome (IBS) Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Irritable Bowel Syndrome (IBS) Therapeutics.
This report studies the global market size of Irritable Bowel Syndrome (IBS) Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Irritable Bowel Syndrome (IBS) Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Valeant Pharmaceuticals International
Ardelyx
Astellas Pharma
Novartis
GlaxoSmithKline
Ironwood Pharmaceuticals
Market Segment by Product Type
Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor
Market Segment by Application
Hospital
Research
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Irritable Bowel Syndrome (IBS) Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Irritable Bowel Syndrome (IBS) Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Irritable Bowel Syndrome (IBS) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Blautix (Strain)
- 1.3.3 Bekinda (IBS-D)
- 1.3.4 SYN-010
- 1.3.5 Tenapanor
- 1.4 Market Segment by Application
- 1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Research
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size
- 2.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue 2014-2025
- 2.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales 2014-2025
- 2.2 Irritable Bowel Syndrome (IBS) Therapeutics Growth Rate by Regions
- 2.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturers
- 3.1.1 Irritable Bowel Syndrome (IBS) Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Irritable Bowel Syndrome (IBS) Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Irritable Bowel Syndrome (IBS) Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Irritable Bowel Syndrome (IBS) Therapeutics Market
- 3.6 Key Manufacturers Irritable Bowel Syndrome (IBS) Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Blautix (Strain) Sales and Revenue (2014-2019)
- 4.1.2 Bekinda (IBS-D) Sales and Revenue (2014-2019)
- 4.1.3 SYN-010 Sales and Revenue (2014-2019)
- 4.1.4 Tenapanor Sales and Revenue (2014-2019)
- 4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Market Share by Type
- 4.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Market Share by Type
- 4.4 Irritable Bowel Syndrome (IBS) Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales by Application
6 United States
- 6.1 United States Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Company
- 6.2 United States Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Type
- 6.3 United States Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Company
- 7.2 European Union Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Type
- 7.3 European Union Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Application
8 China
- 8.1 China Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Company
- 8.2 China Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Type
- 8.3 China Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Company
- 9.2 Rest of World Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Type
- 9.3 Rest of World Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Application
- 9.4 Rest of World Irritable Bowel Syndrome (IBS) Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Irritable Bowel Syndrome (IBS) Therapeutics Sales by Countries
- 9.4.2 Rest of World Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.1.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.1.5 Abbott Laboratories Recent Development
- 10.2 Synergy Pharmaceuticals
- 10.2.1 Synergy Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.2.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.2.5 Synergy Pharmaceuticals Recent Development
- 10.3 Sucampo Pharmaceuticals
- 10.3.1 Sucampo Pharmaceuticals Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.3.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.3.5 Sucampo Pharmaceuticals Recent Development
- 10.4 Valeant Pharmaceuticals International
- 10.4.1 Valeant Pharmaceuticals International Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.4.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.4.5 Valeant Pharmaceuticals International Recent Development
- 10.5 Ardelyx
- 10.5.1 Ardelyx Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.5.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.5.5 Ardelyx Recent Development
- 10.6 Astellas Pharma
- 10.6.1 Astellas Pharma Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.6.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.6.5 Astellas Pharma Recent Development
- 10.7 Novartis
- 10.7.1 Novartis Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.7.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.7.5 Novartis Recent Development
- 10.8 GlaxoSmithKline
- 10.8.1 GlaxoSmithKline Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.8.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.8.5 GlaxoSmithKline Recent Development
- 10.9 Ironwood Pharmaceuticals
- 10.9.1 Ironwood Pharmaceuticals Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome (IBS) Therapeutics
- 10.9.4 Irritable Bowel Syndrome (IBS) Therapeutics Product Introduction
- 10.9.5 Ironwood Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Irritable Bowel Syndrome (IBS) Therapeutics Sales Channels
- 11.2.2 Irritable Bowel Syndrome (IBS) Therapeutics Distributors
- 11.3 Irritable Bowel Syndrome (IBS) Therapeutics Customers
12 Market Forecast
- 12.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Type
- 12.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Application
- 12.4 Irritable Bowel Syndrome (IBS) Therapeutics Forecast by Regions
- 12.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome (IBS) Therapeutics. Industry analysis & Market Report on Irritable Bowel Syndrome (IBS) Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Irritable Bowel Syndrome (IBS) Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome (IBS) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
